Drug intelligence / Profile preview

RenThyroid

Development stage
Unknown
Lead developer
Genus Lifesciences
Administration
Oral
01

Overview

RenThyroid is a prescription desiccated thyroid extract (DTE) developed and manufactured by Genus Lifesciences. Derived from porcine thyroid glands, it contains a standardized combination of the active thyroid hormones levothyroxine (T4) and liothyronine (T3), with each 60 mg of product providing approximately 38 mcg of T4 and 9 mcg of T3. It is indicated as a natural hormone replacement therapy for hypothyroidism of various etiologies, including primary, secondary, and tertiary hypothyroidism, as well as myxedema and cretinism. Additionally, RenThyroid is utilized as a pituitary thyroid-stimulating hormone (TSH) suppressant in the management of thyroid nodules, goiters, and thyroid cancer. The drug functions by providing exogenous hormones that bind to nuclear thyroid hormone receptors, thereby regulating metabolic processes and gene expression normally managed by endogenous thyroid secretions.

Brand names
RenThyroid
Other names
Thyroid Tablets, USPDesiccated Thyroid ExtractDTE
02

Targets

THRA (Thyroid hormone receptor alpha)THRB (Thyroid hormone receptor beta)

Beyond the preview

Go deeper on RenThyroid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RenThyroid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call